Patents by Inventor Paulo Jorge GOUVEIA SIMÕES DA SILVA OLIVEIRA

Paulo Jorge GOUVEIA SIMÕES DA SILVA OLIVEIRA has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11078222
    Abstract: The present disclosure relates to the design and synthesis of new mitochondriotropic antioxidant compounds based on hydroxybenzoic acids and analogues. Furthermore, this disclosure is also related to the methods and uses of the hydroxybenzoic based derivatives and analogues, for example, in the field of human and animal diseases, for instance to treat mitochondrial dysfunction or mitochondrial deficiencies, and cosmetics, for instance to prevent or delay skin aging.
    Type: Grant
    Filed: December 29, 2017
    Date of Patent: August 3, 2021
    Assignees: UNIVERSIDADE DO PORTO, CENTRO DE NEUROCIÊNCIAS E BIOLOGIA CELULAR
    Inventors: Maria Fernanda Martins Borges, Paulo Jorge Gouveia Simõës Da Silva Oliveira, José Carlos Santos Teixeira, Fernando Cagide Fagin, Ana Catarina Gomes Oliveira
  • Patent number: 10913757
    Abstract: The present disclosure relates to the design and development of new hydroxycinnamic derivatives that operate as mitochondriotropic antioxidants. Furthermore, this disclosure is also related to the methods and uses of the hydroxycinnamic derivatives, for example, in the field of human and animal diseases, for instance to treat mitochondrial dysfunction or mitochondrial deficiencies, and cosmetics, for instance to prevent or delay skin aging.
    Type: Grant
    Filed: October 16, 2017
    Date of Patent: February 9, 2021
    Assignees: UNIVERSIDADE DO PORTO, CENTRO DE NEUROCIÊNCIAS E BIOLOGIA CELULAR
    Inventors: Maria Fernanda Martins Borges, Paulo Jorge Gouveia Simões Da Silva Oliveira, JoséCarlos Santos Teixeira, Fernando Cagide Fagin, Ester Sofia Teixeira Benfeito
  • Publication number: 20190330249
    Abstract: The present disclosure relates to the design and synthesis of new mitochondriotropic antioxidant compounds based on hydroxybenzoic acids and analogues. Furthermore, this disclosure is also related to the methods and uses of the hydroxybenzoic based derivatives and analogues, for example, in the field of human and animal diseases, for instance to treat mitochondrial dysfunction or mitochondrial deficiencies, and cosmetics, for instance to prevent or delay skin aging.
    Type: Application
    Filed: December 29, 2017
    Publication date: October 31, 2019
    Inventors: Maria Fernanda MARTINS BORGES, Paulo Jorge GOUVEIA SIMÕËS DA SILVA OLIVEIRA, José Carlos SANTOS TEIXEIRA, Fernando CAGIDE FAGIN, Ana Catarina GOMES OLIVEIRA
  • Publication number: 20190248816
    Abstract: The present disclosure relates to the design and development of new hydroxycinnamic derivatives that operate as mitochondriotropic antioxidants. Furthermore, this disclosure is also related to the methods and uses of the hydroxycinnamic derivatives, for example, in the field of human and animal diseases, for instance to treat mitochondrial dysfunction or mitochondrial deficiencies, and cosmetics, for instance to prevent or delay skin aging.
    Type: Application
    Filed: October 16, 2017
    Publication date: August 15, 2019
    Inventors: Maria Fernanda MARTINS BORGES, Paulo Jorge GOUVEIA SIMÕES DA SILVA OLIVEIRA, José Carlos SANTOS TEIXEIRA, Fernando CAGIDE FAGIN, Ester Sofia TEIXEIRA BENFEITO